The Development and Application of Tritium-Labeled Compounds in Biomedical Research.
autoradiography
protein binding studies
synthesis of tritiated compounds
tritium labeling
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
29 Aug 2024
29 Aug 2024
Historique:
received:
23
07
2024
revised:
25
08
2024
accepted:
28
08
2024
medline:
14
9
2024
pubmed:
14
9
2024
entrez:
14
9
2024
Statut:
epublish
Résumé
With low background radiation, tritiate compounds exclusively emit intense beta particles without structural changes. This makes them a useful tool in the drug discovery arsenal. Thanks to the recent rapid progress in tritium chemistry, the preparation and analysis of tritium-labeled compounds are now much easier, simpler, and cheaper. Pharmacokinetics, autoradiography, and protein binding studies have been much more efficient with the employment of tritium-labeled compounds. This review provides a comprehensive overview of tritium-labeled compounds regarding their properties, synthesis strategies, and applications.
Identifiants
pubmed: 39274956
pii: molecules29174109
doi: 10.3390/molecules29174109
pii:
doi:
Substances chimiques
Tritium
10028-17-8
Radiopharmaceuticals
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : The CAMS Innovation Fund for Medical Sciences
ID : 2022-I2M-1-013